Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
19 03 2020
Historique:
received: 02 05 2019
revised: 09 12 2019
accepted: 07 01 2020
pubmed: 2 2 2020
medline: 15 7 2020
entrez: 2 2 2020
Statut: ppublish

Résumé

Deregulated expression of MYC induces a dependence on the NUAK1 kinase, but the molecular mechanisms underlying this dependence have not been fully clarified. Here, we show that NUAK1 is a predominantly nuclear protein that associates with a network of nuclear protein phosphatase 1 (PP1) interactors and that PNUTS, a nuclear regulatory subunit of PP1, is phosphorylated by NUAK1. Both NUAK1 and PNUTS associate with the splicing machinery. Inhibition of NUAK1 abolishes chromatin association of PNUTS, reduces spliceosome activity, and suppresses nascent RNA synthesis. Activation of MYC does not bypass the requirement for NUAK1 for spliceosome activity but significantly attenuates transcription inhibition. Consequently, NUAK1 inhibition in MYC-transformed cells induces global accumulation of RNAPII both at the pause site and at the first exon-intron boundary but does not increase mRNA synthesis. We suggest that NUAK1 inhibition in the presence of deregulated MYC traps non-productive RNAPII because of the absence of correctly assembled spliceosomes.

Identifiants

pubmed: 32006464
pii: S1097-2765(20)30008-3
doi: 10.1016/j.molcel.2020.01.008
pmc: PMC7086158
pii:
doi:

Substances chimiques

Chromatin 0
MYC protein, human 0
Proto-Oncogene Proteins c-myc 0
Repressor Proteins 0
Protein Kinases EC 2.7.-
NUAK1 protein, human EC 2.7.1.-
RNA Polymerase II EC 2.7.7.-
Protein Phosphatase 1 EC 3.1.3.16

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1322-1339.e11

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests L.W., F.P., and D.M. are employees and shareholders of Bayer AG. The other authors declare no competing interests.

Références

Nat Rev Cancer. 2002 Oct;2(10):764-76
pubmed: 12360279
Biochem J. 2014 Jan 1;457(1):215-25
pubmed: 24171924
Nature. 2015 Sep 17;525(7569):384-8
pubmed: 26331541
Cancer Res. 2018 Sep 15;78(18):5363-5374
pubmed: 30054334
EMBO J. 2018 Mar 1;37(5):
pubmed: 29440228
Genome Res. 2017 Oct;27(10):1658-1664
pubmed: 28904013
Mol Cell. 2012 Mar 30;45(6):814-25
pubmed: 22387027
Biochem Biophys Res Commun. 2008 Apr 25;369(1):149-56
pubmed: 18155661
Mol Cell. 2015 Nov 5;60(3):460-74
pubmed: 26593720
Mol Cell. 2018 Feb 1;69(3):412-425.e6
pubmed: 29395063
Nature. 2019 Mar;567(7749):545-549
pubmed: 30894746
J Biol Chem. 2003 Apr 18;278(16):13819-28
pubmed: 12574161
Cold Spring Harb Symp Quant Biol. 2016;81:79-83
pubmed: 28174256
J Biol Chem. 2008 Dec 19;283(51):35805-14
pubmed: 18842582
EMBO J. 2017 Jul 3;36(13):1854-1868
pubmed: 28408437
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Cell. 2010 Apr 30;141(3):432-45
pubmed: 20434984
Cancer Cell. 2014 Dec 8;26(6):909-922
pubmed: 25490451
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Bioinformatics. 2016 Jul 15;32(14):2089-95
pubmed: 27153568
Bioinformatics. 2009 Jan 15;25(2):288-9
pubmed: 19033274
Nucleic Acids Res. 2015 Jul 13;43(12):5771-84
pubmed: 25990731
Nature. 2004 Nov 18;432(7015):307-15
pubmed: 15549092
Mol Cell. 2019 Dec 19;76(6):896-908.e4
pubmed: 31677974
Mol Cell. 2014 Mar 6;53(5):779-90
pubmed: 24560925
Nat Commun. 2019 Feb 6;10(1):620
pubmed: 30728358
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70
pubmed: 21307310
Nucleic Acids Res. 2014 Jan;42(Database issue):D358-63
pubmed: 24234451
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):816-825
pubmed: 30591567
Biochem Soc Trans. 2017 Feb 8;45(1):89-99
pubmed: 28202662
J Cell Biochem. 2019 Sep;120(9):16088-16107
pubmed: 31090959
Mol Cell Proteomics. 2015 Jan;14(1):205-15
pubmed: 25394399
Methods Mol Biol. 2017;1550:83-98
pubmed: 28188525
BMC Genomics. 2014 Apr 15;15:284
pubmed: 24735413
Cancer Discov. 2018 May;8(5):632-647
pubmed: 29500295
Mol Cell. 2011 Mar 18;41(6):733-46
pubmed: 21353615
Oncogene. 2018 Feb 22;37(8):982-992
pubmed: 29106388
J Biol Chem. 2010 Aug 6;285(32):24466-76
pubmed: 20516061
Nat Rev Cancer. 2015 Oct;15(10):593-607
pubmed: 26383138
Nature. 2015 Jul 2;523(7558):96-100
pubmed: 25970242
Bioinformatics. 2004 Nov 22;20(17):3246-8
pubmed: 15180930
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Mol Cell. 2018 Dec 6;72(5):836-848.e7
pubmed: 30415952
Nat Methods. 2018 Mar;15(3):213-220
pubmed: 29431736
Cell. 2015 Apr 23;161(3):526-540
pubmed: 25910207
Cell. 2014 Nov 20;159(5):1126-1139
pubmed: 25416950
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Mol Cell. 2012 May 11;46(3):311-24
pubmed: 22483619
Nat Commun. 2012;3:994
pubmed: 22871813
Cold Spring Harb Symp Quant Biol. 2011;76:369-74
pubmed: 21960526
J Biol Chem. 2011 Mar 18;286(11):8722-8
pubmed: 21209085
Cell Death Dis. 2014 Apr 10;5:e1157
pubmed: 24722282
Genes Dev. 2011 Jun 1;25(11):1147-58
pubmed: 21576257
Genes Dev. 2011 May 1;25(9):972-83
pubmed: 21536736
Nature. 2018 Jun;558(7710):460-464
pubmed: 29899453
Mol Cell. 2018 Oct 18;72(2):369-379.e4
pubmed: 30340024
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Cell Rep. 2017 Dec 19;21(12):3483-3497
pubmed: 29262328
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Chem Biol. 2007 Sep;3(9):570-5
pubmed: 17643112
Cell. 2012 Mar 30;149(1):22-35
pubmed: 22464321
Mol Cell Proteomics. 2019 Jul;18(7):1468-1478
pubmed: 30967486
Nat Chem Biol. 2007 Sep;3(9):576-83
pubmed: 17643111
Nat Chem Biol. 2018 Feb;14(2):163-170
pubmed: 29251720
Mol Cell. 2006 Sep 15;23(6):819-29
pubmed: 16973434
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Nature. 2014 Jul 24;511(7510):483-7
pubmed: 25043018
Cell Rep. 2014 Sep 11;8(5):1347-53
pubmed: 25176652
Cell. 2014 Nov 20;159(5):1110-1125
pubmed: 25416949
Mol Cell. 2018 Feb 15;69(4):648-663.e7
pubmed: 29398447
Biochem J. 2014 Jul 15;461(2):233-45
pubmed: 24785407
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
J Mol Biol. 2017 Jul 7;429(14):2178-2191
pubmed: 28576472
Nat Commun. 2018 Aug 29;9(1):3502
pubmed: 30158517
Curr Protoc Bioinformatics. 2014 Sep 08;47:11.12.1-34
pubmed: 25199790
PLoS Genet. 2013 Oct;9(10):e1003885
pubmed: 24204300
Nature. 2012 Mar 28;483(7391):608-12
pubmed: 22460906
Genes Dev. 2016 Jan 1;30(1):117-31
pubmed: 26728557
EMBO Mol Med. 2018 Jun;10(6):
pubmed: 29769258
Cell Rep. 2018 Oct 2;25(1):259-269.e5
pubmed: 30282034
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Genes Dev. 2014 Aug 15;28(16):1800-14
pubmed: 25128497
Nat Biotechnol. 2015 Sep;33(9):990-5
pubmed: 26280412
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Cell. 2016 Dec 1;167(6):1455-1467
pubmed: 27912056
Mol Cell. 2019 May 16;74(4):674-687.e11
pubmed: 30928206
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Oncogene. 2011 Jun 30;30(26):2933-42
pubmed: 21317932
Sci Signal. 2010 Mar 30;3(115):ra25
pubmed: 20354225
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Anal Chem. 2003 Feb 1;75(3):663-70
pubmed: 12585499
J Clin Invest. 2015 Jun;125(6):2293-306
pubmed: 25915584
Nature. 2009 Apr 9;458(7239):762-5
pubmed: 19219026

Auteurs

Giacomo Cossa (G)

Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Isabelle Roeschert (I)

Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Florian Prinz (F)

Lab GBM Research 5, Research & Development, Pharmaceuticals, Bayer AG, Building S155, 13342 Berlin, Germany.

Apoorva Baluapuri (A)

Cancer Systems Biology Group, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Raphael Silveira Vidal (R)

Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Christina Schülein-Völk (C)

Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Yun-Chien Chang (YC)

Technical University of Munich, Emil-Erlenmeyer Forum 5, 85354 Freising, Germany.

Carsten Patrick Ade (CP)

Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Guido Mastrobuoni (G)

Berlin Institute for Medical Systems Biology at The Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany.

Cyrille Girard (C)

Department of Cellular Biochemistry, Max-Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany.

Lars Wortmann (L)

Lab GBM Research 5, Research & Development, Pharmaceuticals, Bayer AG, Building S155, 13342 Berlin, Germany.

Susanne Walz (S)

Comprehensive Cancer Center Mainfranken, Core Unit Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Reinhard Lührmann (R)

Department of Cellular Biochemistry, Max-Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany.

Stefan Kempa (S)

Berlin Institute for Medical Systems Biology at The Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany.

Bernhard Kuster (B)

Technical University of Munich, Emil-Erlenmeyer Forum 5, 85354 Freising, Germany.

Elmar Wolf (E)

Cancer Systems Biology Group, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Dominik Mumberg (D)

Lab GBM Research 5, Research & Development, Pharmaceuticals, Bayer AG, Building S155, 13342 Berlin, Germany.

Martin Eilers (M)

Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany. Electronic address: martin.eilers@biozentrum.uni-wuerzburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH